Live Report From ACHEMA - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Live Report From ACHEMA



Day Three at ACHEMA and I've seen even more innovations. here are some of the highlights.

Medelpharm have a tablet compressor that can make 900 single or 300 triple layer tablets in an hour. It does the entire process. It can make tablets of up to five layers and three different types of powder are possible. A touch of a button allows for the weighing of each layer independently. Each step is monitored for analysis, force, displacement and ejection. It is also remarkably easy to dismantle and reassemble.

Sartorius have a massive array of products at the event. Their Picus pipette won a red-dot award in 2012. It is durable yet light and it claims to protect from RSI. Their Biostat D-DCU is a compact sterilisation in-place bioreactor. It comes in a variety of sizes, from 10L to 200L. Its modular design enables easy configuration to meet individual customer needs.

Sartorius also announced that they have teamed up with BOSCH. Their preVAS system is a complete, pre-validated single-use filling system. It is pre-Validated, pre-Assembled and pre-Sterilised. It is flexible, safe, and quick. What's more it uses the BOSCH peristaltic pump, there is a trolley version, and hybrid versions are available.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here